<DOC>
	<DOCNO>NCT01424774</DOCNO>
	<brief_summary>This study perform clinical site administer CardioGen-82® patient January July 2011 . The patient enrol ( i.e. , `` target date patient '' ) dose end use CardioGen-82® generator last day generator use generator use immediately prior recall generator ( i.e. , `` target date generator '' ) . These patient receive drug elute recalled generator . Of patient , plan 100 patient enter trial .</brief_summary>
	<brief_title>Prospective Evaluation Strontium Patients After CardioGen-82 PET MPI Scanning</brief_title>
	<detailed_description>This clinical study protocol use three tier approach consist follow examination : 1 . Patient examination Survey Meter : Patients agree test clinical site first evaluate use survey meter . In patient radiation count ≥ 2 time background count use standard survey meter , presence Sr-82 and/or Sr-85 assess quantitative reading calibrate portable isotope identifier . 2 . Patient examination Portable Isotope Identifier : This examination do use portable isotope identifier , supply Sponsor study site . An assessor , independent study site , perform examination . In patient whose radiation count ≥ 2 time background count use standard survey meter , presence Sr-82 and/or Sr-85 assess quantitative reading calibrate portable isotope identifier . The reading forward along date reading , date patient 's CardioGen-82® scan , total dose CardioGen-82® administer patient , independent medical expert , independent study site , back-calculate estimate dose Sr-82 and/or Sr-85 data . 3 . Patient examination Oak Ridge National Laboratory : Any patient whose estimate dose Sr-82 exceeds specify limit 0.02 microcuries per mCi Rb-82 administer , and/or whose estimate dose Sr-85 exceeds specify limit 0.2 microcuries per mCi Rb-82 administer , ask travel Oak Ridge National Laboratory Tennessee , accurate whole body scan . Scan data Oak Ridge National Laboratories analyze one independent medical expert accurately back-calculate exposure Sr-82 and/or Sr-85 , estimate health hazard patient .</detailed_description>
	<criteria>Enroll patient study patient meet follow inclusion criterion : Male female Gave inform consent participate study Received CardioGen82® elute generator last usage day generator use prior generator recall . Exclude patient study patient previously enrol complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Radiation Exposure</keyword>
	<keyword>Rubidium 82</keyword>
	<keyword>Strontium 82</keyword>
	<keyword>Strontium 85</keyword>
</DOC>